Serge Saxonov - 26 Feb 2026 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
02 Mar 2026, 16:24:35 UTC
Previous filing
25 Feb 2026
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saxonov Serge Chief Executive Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Randy Wu, as Attorney-in-Fact for Serge Saxonov 02 Mar 2026 0001786720

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +157,895 +15% $0.000000 1,219,819 26 Feb 2026 Direct F1
holding TXG Class A Common Stock 27 26 Feb 2026 See footnote F2
holding TXG Class A Common Stock 213,250 26 Feb 2026 See footnote F3
holding TXG Class A Common Stock 58,000 26 Feb 2026 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.